Fredun Pharmaceuticals Ltd - 539730 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 28,2021 for Daulat Nariman Medhora Fredun Pharmaceuticals Ltd - 539730 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 23, 2021 for Dr. Mrs. Daulat MedHora Fredun Pharmaceuticals Ltd - 539730 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fredun Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Intimation for Resignation of Company Secretary and Compliance officer Fredun Pharmaceuticals Ltd - 539730 - Submission Of Voting Results As Per Regulation 44 (3) Of SEBI Listing Obligation And Disclosure Requirements) Regulation, 2015
Please find herewith the Voting Results as per Regulation 44 (3) of SEBI Listing Obligation and Disclosure Requirements) Regulation, 2015 for the Resolutions as set out in the Notice of Extra Ordinary General Meeting. Fredun Pharmaceuticals Ltd - 539730 - Submission Of Scrutinizer Report
Please find enclosed herewith the Report as issued by the Scrutinizer for the Remote E Voting and same day E-voting conducted for the purpose of Extra Ordinary General Meeting. Fredun Pharmaceuticals Ltd - 539730 - Submission Of Proceedings Of Extra Ordinary General Meeting
Pursuant to Regulation 30, Part A of Schedule - III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the summary of proceedings of the Extra Ordinary General Meeting (EGM) of M/s Fredun Pharmaceuticals Limited held on Tuesday 19th October, 2021 through Video Conferencing or Other Audio Visual Means ('VC/ OAVM') to transact the Business as stated in notice of the Meeting. Fredun Pharmaceuticals Ltd - 539730 - Shareholding for the Period Ended September 30, 2021
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder the confirmation certificate received from the SEBI Registered Share Transfer Agent viz. Purva Sharegistry (India) Pvt. Ltd. for the quarter ended September 30, 2021. Fredun Pharmaceuticals Ltd - 539730 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ankita JoshiDesignation :- Company Secretary and Compliance Officer